Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
Clinical trial NCT04382053 · COMPLETED
Trial details
- NCT number
- NCT04382053
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-27
- Primary completion
- 2020-12-10
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.